Anna Becker studied Clinical Psychology and Neuroscience at the University of Basel. Since 2020 she has been a PhD candidate in the psychopharmacology research group of Prof. Matthias Liechti at the University Hospital Basel where she investigates the role of 5-HT2A receptor down-regulation and antagonism in the acute effects of psilocybin and LSD. In this function, she has accompanied over 200 psychedelic experiences. She is interested in the basic physiological processes of psychedelics as well as their psychotherapeutic applications. She has started psychotherapy training in 2021 and has been working clinically since. Hence, she was able to conduct LSD assisted therapy sessions within the “LSD against depression” phase II study in Basel.